Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Munich - Delayed Quote EUR

Alnylam Pharmaceuticals Inc (DUL.MU)

Compare
235.50
+3.20
+(1.38%)
As of 8:04:27 AM GMT+1. Market Open.
All numbers in thousands
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
4,239,983
3,829,880
3,546,359
3,643,304
Total Liabilities Net Minority Interest
4,172,895
4,050,524
3,704,582
3,055,101
Total Equity Gross Minority Interest
67,088
-220,644
-158,223
588,203
Total Capitalization
1,091,709
800,132
858,719
1,263,900
Common Stock Equity
67,088
-220,644
-158,223
588,203
Capital Lease Obligations
271,427
284,611
303,306
321,895
Net Tangible Assets
67,088
-220,644
-158,223
588,203
Working Capital
2,109,013
2,014,911
1,924,332
2,112,866
Invested Capital
1,091,709
800,132
858,719
1,263,900
Tangible Book Value
67,088
-220,644
-158,223
588,203
Total Debt
1,296,048
1,305,387
1,320,248
997,592
Net Debt
58,193
208,088
150,548
--
Share Issued
129,294
125,794
123,925
120,182
Ordinary Shares Number
129,294
125,794
123,925
120,182
12/31/2021 - 2/5/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers